BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cooper GS. Should We Abandon Current Hepatocellular Carcinoma Screening Practices? Gastroenterology 2018;155:972-4. [DOI: 10.1053/j.gastro.2018.09.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Aboismaiel MG, El-mesery M, El-karef A, El-shishtawy MM. Hesperetin upregulates Fas/FasL expression and potentiates the antitumor effect of 5-fluorouracil in rat model of hepatocellular carcinoma. Egyptian Journal of Basic and Applied Sciences 2020;7:20-34. [DOI: 10.1080/2314808x.2019.1707627] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Abd Elhameed AG, Helal MG, Said E, Salem HA. Saxagliptin defers thioacetamide-induced hepatocarcinogenesis in rats: A novel suppressive impact on Wnt/Hedgehog/Notch1 signaling. Environ Toxicol Pharmacol 2021;86:103668. [PMID: 33945853 DOI: 10.1016/j.etap.2021.103668] [Reference Citation Analysis]
3 Qian X, Yan X, Zhai X, Li N, Qu C, Lu F. Hepatocellular Carcinoma Surveillance and Treatment: A Way to Reduce Cancer-related Mortality in Cirrhotic Patients. J Clin Transl Hepatol 2019;7:1-2. [PMID: 30944811 DOI: 10.14218/JCTH.2019.00002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
4 Casler K, Chaney A. Cirrhosis: An evidence-based approach. Nursing 2021;51:24-34. [PMID: 33953095 DOI: 10.1097/01.NURSE.0000731828.24893.bb] [Reference Citation Analysis]